PD-L1 testing in advanced stage lung cancer using cytology samples: Suitability and reporting issues. Comparison between two tertiary referral centers-Reference-Cited by-同舟云学术

PD-L1 testing in advanced stage lung cancer using cytology samples: Suitability and reporting issues. Comparison between two tertiary referral centers

Published:2021-01-25 Issue: Volume: Page:001-006
ISSN:2640-7809
Container-title:Annals of Cytology and Pathology
language:
Short-container-title:Ann Cytol Pathol

Author:

Elshiekh Mohamed,Spinelli Manuela,Iles Sandra,Hopcroft Danielle,Trivedi Pritesh,Gupta Nandita,Bhagwat Priya,Viola Patrizia

Publisher

Peertechz Publications Private Limited

Link

https://www.peertechzpublications.com/articles/ACP-6-122.pdf

Reference31 articles.

1. 1. de Groot PM, Wu CC, Carter BW, Munden RF (2018) The epidemiology of lung cancer. Transl Lung Cancer Res 7: 220-233. Link: https://bit.ly/2KIlpPA

2. 2. Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, et al. (2018) Programmed death-ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Cancer Cytopathol 126: 342-352. Link: https://bit.ly/36atIv1

3. 3. Russell-Goldman E, Kravets S, Dahlberg SE, Sholl LM, Vivero M (2018) Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas. Cancer Cytopathol 126: 253-263. Link: https://bit.ly/36aefeC

4. 4. Heymann JJ, Bulman WA, Swinarski D, Pagan CA, Crapanzano JP, et al. (2017) {PD}-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens. Cancer Cytopathol 125: 896-907. Link: https://bit.ly/39eV5pH

5. 5. Skov BG, Skov T (2017) Paired Comparison of {PD}-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With {PD}-L1 {IHC} 28-8pharmDx and {PD}-L1 {IHC} 22C3pharmDx. Appl Immunohistochem Mol Morphol [Internet]. 25: 453-459. Link: https://bit.ly/3a0oOSz